Results 141 to 150 of about 54,944 (282)
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.Abstract Background Mutations in DMD affect not only muscles but also the brain. Cases of schizophrenia with DMD mutations have been described previously. Although female dystrophinopathy often has a milder phenotype, some affected females also have intellectual disabilities and psychiatric disorders.
Shusei Arafuka +15 more
wiley +1 more source
Pediatric catatonia: A case report and review of the management
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.Abstract Background Catatonia is when someone does not respond to stimuli or their environment whilst awake. Catatonia can present in a variety of ways, including a change in movement, speech, and behavior. There is limited research on the causes and management of catatonia in an adult population and even more so in the pediatric population.
Alison Thornton, Russell Birkett
wiley +1 more source
Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.Clozapine (CLOZ) is often avoided in treatment‐resistant schizophrenia with comorbid epilepsy due to seizure risks. We report a successful case managed through a cautious CLOZ titration guided by multimodal monitoring, including clinical scales and blood tests such as C‐reactive protein (CRP), CLOZ levels, and anti‐seizure medication (ASM) levels ...
Toru Horinouchi +5 more
wiley +1 more source
Seeing Voices: Potential Neuroscience Contributions to a Reconstruction of Legal Insanity [PDF]
, 2016 Part I of this Article explains the insanity defense in the United States. Next, Part II discusses some of the brain-based research about mental illness, focusing on schizophrenia research.
Moriarty, Jane Campbell
core +1 more source
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.This graphical summary illustrates the efficacy and safety of brexpiprazole (2–4 mg) in patients with schizophrenia. The meta‐analysis demonstrates significant improvement in clinical outcomes, with reductions in Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression ‐ Severity scale (CGI‐S) scores, indicating better symptom ...
Sher Bano +14 more
wiley +1 more source
An adolescent hospitalised after polysubstance abuse: A case report
General Psychiatry, Volume 39, Issue 3, June 2026.
Haifeng Zhang, Jialong Yi, Xin Yu
wiley +1 more source
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.We performed longitudinal evaluation using magnetic resonance imaging (MRI) and dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) in a case of organophosphate‐induced toxic parkinsonism. Fluid‐attenuated inversion recovery (FLAIR) images showed bilateral striatal hyperintensity in the acute phase, followed by reduction of ...
Shuhei Nakao +6 more
wiley +1 more source
Seventy Years of Treating Delusional Disorder with Antipsychotics: A Historical Perspective. [PDF]
Biomedicines, 2022 González-Rodríguez A +3 more
europepmc +1 more source
NEUROPSYCHOLOGICAL PROFILE OF DELUSIONAL DISORDER
Psychiatria Danubina, 2009 Previous studies concerned with neuropsychological aspect of delusions, were mainly focused on specific forms of this disorder, such as Cotard or Capgras type of delusions. Comparatively small numbers of investigations were concerned with cognitive deficiencies accompanying the delusions.
Leposavić, Ivana +2 more
openaire +2 more sources